Urothelial Bladder Carcinoma | Data + Perspectives: Clinical Investigators Discuss the Optimal Management of Urothelial Bladder Carcinoma - a podcast by Dr Neil Love
from 2020-03-26T20:48:01
::
::
Proceedings from a CME symposium held at the 2020 Genitourinary Cancers Symposium. Featuring perspectives from Drs Peter H O’Donnell, Daniel P Petrylak, Elizabeth R Plimack, Jonathan E Rosenberg and Guru Sonpavde.
- Introduction
-
- Program Overview: Dr Neil Love (00:00)
- Immune Checkpoint Inhibitors for Patients with Nonmetastatic Urothelial Bladder Cancer (UBC)
- Role of Anti-PD-1/PD-L1 Antibodies in the Up-Front Management of Advanced UBC
-
- Roundtable Discussion (25:17)
- Faculty Presentation — Dr Rosenberg (39:50)
- Application of Anti-PD-1/PD-L1 Antibodies for Progressive Metastatic Disease; Ongoing Investigation of Immune Checkpoint Inhibitors in Advanced UBC
-
- Roundtable Discussion (54:11)
- Faculty Presentation — Dr O’Donnell (1:02:25)
- Approved and Investigational Antibody-Drug Conjugates for Advanced UBC
-
- Roundtable Discussion (1:13:41)
- Faculty Presentation — Dr Petrylak (1:23:53)
- FGFR-Targeted Strategies in Advanced UBC
-
- Roundtable Discussion (1:35:35)
- Faculty Presentation — Dr Sonpavde (1:45:18)
CME information and select publications
Further episodes of Research To Practice | Oncology Videos
Further podcasts by Dr Neil Love
Website of Dr Neil Love